Table 1.
Patient characteristics and SPAG9 expression
| Characteristics | Number | Negative/weak (%) | Positive (%) | p |
|---|---|---|---|---|
| Age | ||||
| <60 | 14 | 8 (57.14%) | 6 (48.26%) | 0.544 |
| ≥60 | 48 | 23 (47.91%) | 25 (52.09%) | |
| Gleason Score | ||||
| <8 | 24 | 17 (70.83%) | 7 (29.17%) | 0.019 |
| ≥8 | 38 | 14 (36.84%) | 24 (63.16%) | |
| Tumor stage | ||||
| pT2a-c | 32 | 22 (68.75%) | 10 (31.25%) | 0.002 |
| pT3a-4 | 30 | 9 (30.00%) | 21 (70.00%) | |
| Nodal status | ||||
| pN0 | 43 | 23 (53.48%) | 20 (46.52%) | 0.582 |
| pN1 | 29 | 8 (42.10%) | 11 (57.90%) | |
| PSA levels | ||||
| <10 ng/mL | 27 | 16 (59.26%) | 11 (40.74%) | 0.306 |
| ≥10 ng/mL | 35 | 15 (42.86%) | 20 (57.14%) |
P-values are obtained from Chi-square test.